Many TNBC tumors exhibit elevated intracellular iron levels and heightened oxidative stress, creating a biological reliance on redox-active metals to sustain proliferation and epigenetic modifications ...
GA, UNITED STATES, February 4, 2026 / EINPresswire.com / — Researchers have developed a new biomimetic nanocomposite ...
News-Medical.Net on MSN
Precision mRNA vaccine strategy shows early promise for improving TNBC relapse risk
By Vijay Kumar Malesu A pioneering personalized mRNA vaccine study reveals lasting immune responses in triple-negative breast cancer, offering early signals that tailored cancer vaccination may help ...
Researchers at The University of Texas MD Anderson Cancer Center have developed a new computational approach designed to ...
Leronlimab-mediated CCR5 blockade modulates T-Cell exhaustion pathways and PD-L1 Biology relevant to ICI responseDurable Clinical Observations ...
Gilead Sciences, Inc. shares have risen more than 43% over the past year. Click here to find out why GILD stock is a Sell.
Researchers at The University of Texas MD Anderson Cancer Center have developed a new computational approach designed to better account for changes in gene expression within tumors relative to their ...
By Ben Barry A woman credits her dog with saving her life after his unusual behavior led to a breast cancer diagnosis. Chase ...
Researchers at The University of Texas MD Anderson Cancer Center have developed a new computational approach designed to ...
In an experimental trial, a personalized mRNA vaccine was tested in 14 individuals with an aggressive form of breast cancer. It trained immune cells to target cancer-specific mutant proteins, inducing ...
Cancer survivor and author Charissa Bates turned her healing journey into hope by building a Little Free Library and ...
GlobalData on MSN
CStone secures FDA clearance to begin CS2009 Phase II trial
Recruitment is ongoing in China and Australia, with IND clearance now obtained in the US.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results